208 related articles for article (PubMed ID: 24231739)
21. Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein.
Kemeny S; Dery D; Loboda Y; Rovner M; Lev T; Zuri D; Finberg JP; Larisch S
PLoS One; 2012; 7(7):e38837. PubMed ID: 22792159
[TBL] [Abstract][Full Text] [Related]
22. [The role of parkin in Parkinson's disease].
Miklya I; Göltl P; Hafenscher F; Pencz N
Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
[TBL] [Abstract][Full Text] [Related]
23. Parkin interacts with the proteasome subunit alpha4.
Dächsel JC; Lücking CB; Deeg S; Schultz E; Lalowski M; Casademunt E; Corti O; Hampe C; Patenge N; Vaupel K; Yamamoto A; Dichgans M; Brice A; Wanker EE; Kahle PJ; Gasser T
FEBS Lett; 2005 Jul; 579(18):3913-9. PubMed ID: 15987638
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
25. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.
Huynh DP; Scoles DR; Nguyen D; Pulst SM
Hum Mol Genet; 2003 Oct; 12(20):2587-97. PubMed ID: 12925569
[TBL] [Abstract][Full Text] [Related]
26. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
Wang C; Ko HS; Thomas B; Tsang F; Chew KC; Tay SP; Ho MW; Lim TM; Soong TW; Pletnikova O; Troncoso J; Dawson VL; Dawson TM; Lim KL
Hum Mol Genet; 2005 Dec; 14(24):3885-97. PubMed ID: 16278233
[TBL] [Abstract][Full Text] [Related]
27. Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition.
Bandopadhyay R; Kingsbury AE; Muqit MM; Harvey K; Reid AR; Kilford L; Engelender S; Schlossmacher MG; Wood NW; Latchman DS; Harvey RJ; Lees AJ
Neurobiol Dis; 2005 Nov; 20(2):401-11. PubMed ID: 15894486
[TBL] [Abstract][Full Text] [Related]
28. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
Vercammen L; Van der Perren A; Vaudano E; Gijsbers R; Debyser Z; Van den Haute C; Baekelandt V
Mol Ther; 2006 Nov; 14(5):716-23. PubMed ID: 16914382
[TBL] [Abstract][Full Text] [Related]
29. Parkin ubiquitinates and promotes the degradation of RanBP2.
Um JW; Min DS; Rhim H; Kim J; Paik SR; Chung KC
J Biol Chem; 2006 Feb; 281(6):3595-603. PubMed ID: 16332688
[TBL] [Abstract][Full Text] [Related]
30. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
31. S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease.
Sunico CR; Nakamura T; Rockenstein E; Mante M; Adame A; Chan SF; Newmeyer TF; Masliah E; Nakanishi N; Lipton SA
Mol Neurodegener; 2013 Aug; 8():29. PubMed ID: 23985028
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathways of neurodegeneration in Parkinson's disease.
Dawson TM; Dawson VL
Science; 2003 Oct; 302(5646):819-22. PubMed ID: 14593166
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells.
Yang H; Zhou HY; Li B; Niu GZ; Chen SD
J Neuroimmune Pharmacol; 2007 Sep; 2(3):276-83. PubMed ID: 18040862
[TBL] [Abstract][Full Text] [Related]
34. Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches.
Ozgul S; Kasap M; Akpinar G; Kanli A; Güzel N; Karaosmanoglu K; Baykal AT; Iseri P
Neurochem Int; 2015; 85-86():1-13. PubMed ID: 25865804
[TBL] [Abstract][Full Text] [Related]
35. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.
Joch M; Ase AR; Chen CX; MacDonald PA; Kontogiannea M; Corera AT; Brice A; Séguéla P; Fon EA
Mol Biol Cell; 2007 Aug; 18(8):3105-18. PubMed ID: 17553932
[TBL] [Abstract][Full Text] [Related]
36. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
37. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
[TBL] [Abstract][Full Text] [Related]
38. Regulation of DNA repair by parkin.
Kao SY
Biochem Biophys Res Commun; 2009 May; 382(2):321-5. PubMed ID: 19285961
[TBL] [Abstract][Full Text] [Related]
39. Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.
Schlossmacher MG; Shimura H
Methods Mol Biol; 2005; 301():351-69. PubMed ID: 15917645
[TBL] [Abstract][Full Text] [Related]
40. Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease.
Yamada M; Mizuno Y; Mochizuki H
Hum Gene Ther; 2005 Feb; 16(2):262-70. PubMed ID: 15761265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
